T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.01B |
| 2 |
Gilead Sciences
GILD
|
+$1.25B |
| 3 |
Accenture
ACN
|
+$1.09B |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$1.06B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.84B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.47B |
| 4 |
Eli Lilly
LLY
|
+$1.43B |
| 5 |
Tesla
TSLA
|
+$1.4B |
Sector Composition
| 1 | Technology | 30.49% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.27% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Universal Health Services
UHS
$12B
| $15.8M | ﹤0.01% |
84,008
+625
| +0.7% | +$117K |
|
1002
Amphastar Pharmaceuticals
AMPH
$1.26B
| $15.7M | ﹤0.01% |
541,221
-25,435
| -4% | -$737K |
|
1003
Flutter Entertainment
FLUT
$48.9B
| $15.7M | ﹤0.01% |
70,786
+7,706
| +12% | +$1.71M |
|
1004
A.O. Smith
AOS
$10.2B
| $15.6M | ﹤0.01% |
238,307
-1,485
| -0.6% | -$97.1K |
|
1005
FormFactor
FORM
$2.4B
| $15.5M | ﹤0.01% |
547,717
+2,826
| +0.5% | +$80K |
|
1006
Erie Indemnity
ERIE
$16.9B
| $15.4M | ﹤0.01% |
36,839
+478
| +1% | +$200K |
|
1007
TG Therapeutics
TGTX
$5B
| $15.4M | ﹤0.01% |
390,528
+93,427
| +31% | +$3.68M |
|
1008
Bright Horizons
BFAM
$6.23B
| $15.4M | ﹤0.01% |
121,181
-258,078
| -68% | -$32.8M |
|
1009
First Citizens BancShares
FCNCA
$24.2B
| $15.4M | ﹤0.01% |
8,299
+201
| +2% | +$373K |
|
1010
Bunge Global
BG
$16B
| $15.4M | ﹤0.01% |
200,977
-3,056
| -1% | -$234K |
|
1011
Solventum
SOLV
$12.7B
| $15.3M | ﹤0.01% |
201,041
+499
| +0.2% | +$37.9K |
|
|
ITCI
1012
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $15.2M | ﹤0.01% |
115,424
-474,482
| -80% | -$62.6M |
|
1013
PennyMac Financial
PFSI
$6.36B
| $15.2M | ﹤0.01% |
152,078
+17,643
| +13% | +$1.77M |
|
1014
Paycom
PAYC
$12B
| $15.2M | ﹤0.01% |
69,621
+363
| +0.5% | +$79.3K |
|
1015
Sarepta Therapeutics
SRPT
$1.93B
| $15.2M | ﹤0.01% |
238,248
-3,415
| -1% | -$218K |
|
1016
Pinnacle West Capital
PNW
$10.4B
| $15.1M | ﹤0.01% |
158,616
+2,028
| +1% | +$193K |
|
1017
Interpublic Group of Companies
IPG
$9.63B
| $14.9M | ﹤0.01% |
549,239
+20,202
| +4% | +$549K |
|
1018
Leonardo DRS
DRS
$11.3B
| $14.9M | ﹤0.01% |
453,560
-382,733
| -46% | -$12.6M |
|
1019
Skyworks Solutions
SWKS
$10.9B
| $14.9M | ﹤0.01% |
230,731
+1,974
| +0.9% | +$128K |
|
1020
iShares Core MSCI EAFE ETF
IEFA
$155B
| $14.9M | ﹤0.01% |
196,585
-206,394
| -51% | -$15.6M |
|
1021
Interactive Brokers
IBKR
$27.8B
| $14.8M | ﹤0.01% |
357,288
+95,792
| +37% | +$3.97M |
|
1022
Eastman Chemical
EMN
$7.55B
| $14.7M | ﹤0.01% |
166,544
+1,468
| +0.9% | +$129K |
|
1023
Host Hotels & Resorts
HST
$12B
| $14.5M | ﹤0.01% |
1,021,599
-3,726,586
| -78% | -$53M |
|
1024
Essent Group
ESNT
$6.21B
| $14.5M | ﹤0.01% |
250,956
+7,046
| +3% | +$407K |
|
1025
Berkshire Hathaway Class A
BRK.A
$1.05T
| $14.4M | ﹤0.01% |
18
| – | – |
|